triple negative breast cancer cell line hcc1806 Search Results


hcc1806  (ATCC)
97
ATCC hcc1806
Hcc1806, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/pm25391896-45-8-19?v=ATCC
Average 97 stars, based on 1 article reviews
hcc1806 - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
er  (ATCC)
99
ATCC er
Er, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/pmc02844056-225-0-25?v=ATCC
Average 99 stars, based on 1 article reviews
er - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
htb 22 hcc1806 atcc  (ATCC)
99
ATCC htb 22 hcc1806 atcc
Htb 22 Hcc1806 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/pm39913285-188-234-237?v=ATCC
Average 99 stars, based on 1 article reviews
htb 22 hcc1806 atcc - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
human breast cancer cell lines  (ATCC)
95
ATCC human breast cancer cell lines
Human Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/pm31894262-21-0-32?v=ATCC
Average 95 stars, based on 1 article reviews
human breast cancer cell lines - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
human tnbc cell lines  (ATCC)
96
ATCC human tnbc cell lines
Proliferation and viability of <t>TNBC</t> cells and non-tumorigenic breast cells after treatment with nor-wogonin and structurally related compounds. A. Chemical structures of nor-wogonin, wogonin, and wogonoside. B. Effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on the proliferation of TNBC <t>cells</t> <t>(MDA-MB-231,</t> BT-549, <t>HCC70,</t> and <t>HCC1806)</t> and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by BrdU incorporation assays. Dimethyl sulfoxide (DMSO vehicle) was used as a negative control. C. The cytotoxic effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by trypan blue exclusion assays. DMSO was used as a vehicle control. Data are expressed as the means ± SD based on three independent experiments.
Human Tnbc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/pmc06536637-122-0-19?v=ATCC
Average 96 stars, based on 1 article reviews
human tnbc cell lines - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
cell lines cell lines  (ATCC)
95
ATCC cell lines cell lines
Proliferation and viability of <t>TNBC</t> cells and non-tumorigenic breast cells after treatment with nor-wogonin and structurally related compounds. A. Chemical structures of nor-wogonin, wogonin, and wogonoside. B. Effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on the proliferation of TNBC <t>cells</t> <t>(MDA-MB-231,</t> BT-549, <t>HCC70,</t> and <t>HCC1806)</t> and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by BrdU incorporation assays. Dimethyl sulfoxide (DMSO vehicle) was used as a negative control. C. The cytotoxic effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by trypan blue exclusion assays. DMSO was used as a vehicle control. Data are expressed as the means ± SD based on three independent experiments.
Cell Lines Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/pm41720851-195-0-18?v=ATCC
Average 95 stars, based on 1 article reviews
cell lines cell lines - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
cell lines mda mb 231 atcc htb 26 mda mb 468 atcc htb 132 hcc1806 atcc crl  (ATCC)
99
ATCC cell lines mda mb 231 atcc htb 26 mda mb 468 atcc htb 132 hcc1806 atcc crl
Proliferation and viability of <t>TNBC</t> cells and non-tumorigenic breast cells after treatment with nor-wogonin and structurally related compounds. A. Chemical structures of nor-wogonin, wogonin, and wogonoside. B. Effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on the proliferation of TNBC <t>cells</t> <t>(MDA-MB-231,</t> BT-549, <t>HCC70,</t> and <t>HCC1806)</t> and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by BrdU incorporation assays. Dimethyl sulfoxide (DMSO vehicle) was used as a negative control. C. The cytotoxic effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by trypan blue exclusion assays. DMSO was used as a vehicle control. Data are expressed as the means ± SD based on three independent experiments.
Cell Lines Mda Mb 231 Atcc Htb 26 Mda Mb 468 Atcc Htb 132 Hcc1806 Atcc Crl, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/10__1016_slash_j__isci__2026__114863-440-196-199?v=ATCC
Average 99 stars, based on 1 article reviews
cell lines mda mb 231 atcc htb 26 mda mb 468 atcc htb 132 hcc1806 atcc crl - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
insulin atcc mda mb231 hs578t hcc1187 hcc1806 hcc1937 rpmi  (ATCC)
95
ATCC insulin atcc mda mb231 hs578t hcc1187 hcc1806 hcc1937 rpmi
Proliferation and viability of <t>TNBC</t> cells and non-tumorigenic breast cells after treatment with nor-wogonin and structurally related compounds. A. Chemical structures of nor-wogonin, wogonin, and wogonoside. B. Effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on the proliferation of TNBC <t>cells</t> <t>(MDA-MB-231,</t> BT-549, <t>HCC70,</t> and <t>HCC1806)</t> and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by BrdU incorporation assays. Dimethyl sulfoxide (DMSO vehicle) was used as a negative control. C. The cytotoxic effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by trypan blue exclusion assays. DMSO was used as a vehicle control. Data are expressed as the means ± SD based on three independent experiments.
Insulin Atcc Mda Mb231 Hs578t Hcc1187 Hcc1806 Hcc1937 Rpmi, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/pmc06489282__13058_2019_1136_MOESM1_ESM-119-36-37?v=ATCC
Average 95 stars, based on 1 article reviews
insulin atcc mda mb231 hs578t hcc1187 hcc1806 hcc1937 rpmi - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
human tumor cell lines  (ATCC)
99
ATCC human tumor cell lines
Proliferation and viability of <t>TNBC</t> cells and non-tumorigenic breast cells after treatment with nor-wogonin and structurally related compounds. A. Chemical structures of nor-wogonin, wogonin, and wogonoside. B. Effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on the proliferation of TNBC <t>cells</t> <t>(MDA-MB-231,</t> BT-549, <t>HCC70,</t> and <t>HCC1806)</t> and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by BrdU incorporation assays. Dimethyl sulfoxide (DMSO vehicle) was used as a negative control. C. The cytotoxic effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by trypan blue exclusion assays. DMSO was used as a vehicle control. Data are expressed as the means ± SD based on three independent experiments.
Human Tumor Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/pm35864202-266-0-17?v=ATCC
Average 99 stars, based on 1 article reviews
human tumor cell lines - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
breast tumours 4t1  (SLIT2 LTD)
90
SLIT2 LTD breast tumours 4t1
Proliferation and viability of <t>TNBC</t> cells and non-tumorigenic breast cells after treatment with nor-wogonin and structurally related compounds. A. Chemical structures of nor-wogonin, wogonin, and wogonoside. B. Effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on the proliferation of TNBC <t>cells</t> <t>(MDA-MB-231,</t> BT-549, <t>HCC70,</t> and <t>HCC1806)</t> and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by BrdU incorporation assays. Dimethyl sulfoxide (DMSO vehicle) was used as a negative control. C. The cytotoxic effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by trypan blue exclusion assays. DMSO was used as a vehicle control. Data are expressed as the means ± SD based on three independent experiments.
Breast Tumours 4t1, supplied by SLIT2 LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cell+line+hcc1806/pmc11633843-12-14-6?v=SLIT2+LTD
Average 90 stars, based on 1 article reviews
breast tumours 4t1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Proliferation and viability of TNBC cells and non-tumorigenic breast cells after treatment with nor-wogonin and structurally related compounds. A. Chemical structures of nor-wogonin, wogonin, and wogonoside. B. Effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on the proliferation of TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by BrdU incorporation assays. Dimethyl sulfoxide (DMSO vehicle) was used as a negative control. C. The cytotoxic effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by trypan blue exclusion assays. DMSO was used as a vehicle control. Data are expressed as the means ± SD based on three independent experiments.

Journal: Pharmacological reports : PR

Article Title: Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3

doi: 10.1016/j.pharep.2019.01.001

Figure Lengend Snippet: Proliferation and viability of TNBC cells and non-tumorigenic breast cells after treatment with nor-wogonin and structurally related compounds. A. Chemical structures of nor-wogonin, wogonin, and wogonoside. B. Effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on the proliferation of TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by BrdU incorporation assays. Dimethyl sulfoxide (DMSO vehicle) was used as a negative control. C. The cytotoxic effects of nor-wogonin (5–80 μM), wogonin (100 μM), and wogonoside (100 μM) on TNBC cells (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cells (MCF-10A and AG11132) were determined by trypan blue exclusion assays. DMSO was used as a vehicle control. Data are expressed as the means ± SD based on three independent experiments.

Article Snippet: Human TNBC cell lines (MDA-MB-231, BT-549, HCC70, and HCC1806) and non-tumorigenic breast cell line (MCF-10A) were obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA).

Techniques: BrdU Incorporation Assay, Negative Control, Control